erato
Æresmedlem
Ellers verdt å merke seg dette:
As noted yesterday, Moderna has a new reformulated booster that basically stops the Delta variant in its tracks. If we could get this booster out into people’s arms now, vaccinated and not yet vaccinated, we could crush this Delta wave fast.
But we won’t be able to get this booster out into people’s arms fast. It’s in a phase-two trial, which means it still has to get through phase three. The phase-three trial for Moderna’s first vaccine began July 27, 2020, and cut off data collection on November 25, 2020; the company announced the results of the phase-three trial on December 31, 2020. That’s about four months of testing.
Assuming the third phase of testing goes well, Moderna will to submit an emergency-use authorization to the U.S. Food and Drug Administration. Moderna applied for an EUA for its original COVID-19 vaccine on November 30, and the FDA granted it on December 18. That’s about three weeks.
As noted yesterday, Moderna has a new reformulated booster that basically stops the Delta variant in its tracks. If we could get this booster out into people’s arms now, vaccinated and not yet vaccinated, we could crush this Delta wave fast.
But we won’t be able to get this booster out into people’s arms fast. It’s in a phase-two trial, which means it still has to get through phase three. The phase-three trial for Moderna’s first vaccine began July 27, 2020, and cut off data collection on November 25, 2020; the company announced the results of the phase-three trial on December 31, 2020. That’s about four months of testing.
Assuming the third phase of testing goes well, Moderna will to submit an emergency-use authorization to the U.S. Food and Drug Administration. Moderna applied for an EUA for its original COVID-19 vaccine on November 30, and the FDA granted it on December 18. That’s about three weeks.